Becton Dickinson ROE 2010-2024 | BDX

Current and historical return on equity (ROE) values for Becton Dickinson (BDX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Becton Dickinson ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $1.73B $25.91B 6.72%
2024-06-30 $1.41B $25.87B 5.51%
2024-03-31 $1.32B $25.65B 5.13%
2023-12-31 $1.22B $25.33B 4.75%
2023-09-30 $1.42B $25.80B 5.54%
2023-06-30 $1.58B $25.94B 6.18%
2023-03-31 $1.53B $25.69B 5.99%
2022-12-31 $1.52B $25.47B 6.03%
2022-09-30 $1.69B $25.28B 6.79%
2022-06-30 $1.67B $25.49B 6.81%
2022-03-31 $1.83B $24.53B 7.59%
2021-12-31 $1.68B $24.16B 6.93%
2021-09-30 $2.00B $23.68B 8.23%
2021-06-30 $1.87B $24.14B 7.66%
2021-03-31 $1.64B $24.83B 6.74%
2020-12-31 $1.51B $24.66B 6.46%
2020-09-30 $0.77B $23.77B 3.41%
2020-06-30 $0.79B $24.02B 3.61%
2020-03-31 $0.92B $20.95B 4.36%
2019-12-31 $0.76B $21.20B 3.57%
2019-09-30 $1.08B $21.08B 5.07%
2019-06-30 $0.78B $21.50B 3.68%
2019-03-31 $0.93B $21.31B 4.36%
2018-12-31 $0.90B $21.40B 4.22%
2018-09-30 $0.16B $20.99B 0.75%
2018-06-30 $0.62B $21.36B 3.24%
2018-03-31 $-0.10B $21.15B -0.59%
2017-12-31 $0.29B $21.25B 2.15%
2017-09-30 $1.03B $12.95B 10.03%
2017-06-30 $0.76B $12.59B 8.50%
2017-03-31 $1.32B $7.96B 16.85%
2016-12-31 $1.31B $7.58B 16.94%
2016-09-30 $0.98B $7.63B 12.78%
2016-06-30 $1.14B $8.03B 15.13%
2016-03-31 $0.81B $7.67B 11.06%
2015-12-31 $0.69B $7.22B 9.56%
2015-09-30 $0.70B $7.16B 10.43%
2015-06-30 $0.82B $7.25B 13.29%
2015-03-31 $1.08B $7.16B 19.05%
2014-12-31 $1.15B $5.07B 22.10%
2014-09-30 $1.19B $5.05B 22.76%
2014-06-30 $0.97B $5.38B 18.72%
2014-03-31 $0.95B $5.32B 18.86%
2013-12-31 $0.94B $5.08B 19.33%
2013-09-30 $1.29B $5.04B 27.48%
2013-06-30 $1.49B $4.72B 33.32%
2013-03-31 $1.52B $4.59B 34.82%
2012-12-31 $1.53B $4.47B 35.39%
2012-09-30 $1.17B $4.14B 26.63%
2012-06-30 $1.18B $4.24B 25.86%
2012-03-31 $1.20B $4.48B 24.77%
2011-12-31 $1.22B $4.73B 24.42%
2011-09-30 $1.27B $4.83B 25.29%
2011-06-30 $1.37B $5.30B 26.42%
2011-03-31 $1.33B $5.10B 25.91%
2010-12-31 $1.32B $4.88B 25.57%
2010-09-30 $1.32B $5.44B 25.11%
2010-06-30 $1.24B $5.15B 23.91%
2010-03-31 $1.27B $5.15B 24.50%
2009-12-31 $1.24B $5.26B 24.19%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36